Heberden, W. : Commentaries on the History and Cure of Diseases . Wells and Lilly, Boston, 1818.
2.
The fat of the land. Time, January 13, 1961.
3.
Dawber, T.R. , Moore, F.E., AND Mann, G.V.: Coronary heart disease in the framingham study. Am. J. Pub. Health, 47: 4, 1957.
4.
DocK, W.: Research in arteriosclerosis: the first 50 years. Ann. Int. Med., 49: 699, 1958.
5.
Keys, A.: Diet and the epidemiology of coronary heart disease. J. A. M. A.164: 1912, 1957.
6.
Special Report : Dietary fat and its relation to heart attacks and strokes. A report by the Central Committee of the American Heart Association for Medical and Community Programs. Circulation, 23: 133, 1961.
7.
Secret Remedies.What They Cost and What They Contain. Based on analyses made for theBritish Medical Association. British Medical Association , London, 1919.
8.
Starr, P.: Comparative clinical and biochemical effects of the dextro- and levoisomers of thyroxine. A. M. A. Arch. Int. Med., 101: 722, 1958 .
9.
Starr, P.: Depression of the serum cholesterol level in myxedematous patients by an oral dosage of sodium dextro-thyroxine which has no effect on the basal metabolic rate or electrocardiogram. J. Clin. Endocrinol., 20: 116, 1960.
10.
Cohen, B.M. , AND Bindelglass , I.L.: Sodium dextro-thyroxine in the therapy of hypercholesterolemia. Clin. Med., 7: 1781, 1960.
11.
Starr, P.: The therapeutic value of sodium dextro-thyroxine. Clin. Pharmacol. & Ther., 1: 716, 1960.
12.
Starr, P.: Sodium dextro-thyroxine and sodium levo-thyroxine. J. A. M. A.173: 1934, 1960.
13.
Abell, L.L. , Levy, B.B., Brodie , B.B., AND Kendall, F.E.: A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J. Biol. Chem., 195: 357, 1952 .
14.
Grundy, S.M. , AND Griffin, A.C.: Relationship of periodic mental stress to serum lipoproteins and cholesterol levels. J. A. M. A. , 171: 1794, 1959.
15.
Wertlake, P.T. , Wilcox, A.A., Haley , M.I., AND Peterson , J.E.: Variation in serum lipids during mental and emotional stress. Clin. Res., 7: 105, 1959.
16.
Thomas, C.B. , Holljes, H.W.O., AND Eisen-Berg , F.E.: Observations on seasonal variations in total serum cholesterol level among healthy young prisoners . Ann. Int. Med., 54: 413, 1961.
17.
Manley, K.A. , AND Mckusick, V.A.: Serum cholesterol value in a hospital population . Bull. Johns Hopkins Hosp., 107: 213, 1960 .
18.
Cohen, B.M. , AND Bindelglass , I.L.: Prolonged treatment of hypercholesterolemia with sodium dextro-thyroxine. Medecine et Hygiene, No. 506: 464, 1961.
19.
Corday, E., Irving, D.W., AND Jaffe, H.: The treatment of hypercholesterolemia with thyroid analogues in patients with coronary artery disease. Abst. Circulation, 22: 677, 1960.
20.
Mccullagh, P. , AND Sylvester, J.: Data on reversal of hypercholesterolemia in nonhypothyroid states. Symposium on Sodium D-thyroxine and Hypercholesterolemia. Baxter Laboratories, Chicago, 1960.
21.
Larson, F., AND Card, W.: Double-blind study of blood cholesterol lowering with D-thyroxine . Symposium on Sodium D-thyroxine and Hypercholesterolemia . Baxter Laboratories, Chicago , 1960 .
22.
Greene, R., AND Farran, H.E.A.: The physiological activity of D-thyroxine. Brit. Med. J., 2: 1057, 1958.
23.
Boyd, G.S., AND Oliver, M.F.: The effect of certain thyroxine analogues on the serum lipids in human subjects . J. Endocrinol., 21: 33, 1960.
24.
Best, M.M., AND Duncan, C.H.: Comparative effects of thyroxin analogues as hypocholesterolemic agents. Abst . Circulation, 22: 666, 1960.
25.
Davis, O., Sloan, N., Beck, C., AND Bergal, M.: Some observations on the relationships between atherosclerosis, hyperlipemia and D-thyroxine. Medecine et Hygiene, No. 506: 455, 1961 .
26.
Hoobler, S. , et al.: D-thyroxine in the treatment of hypercholesterolemia . J. Mich. Med. Soc., 59: 1704, 1960.
27.
Oliver, M.F. , AND Boyd, G.S.: Reduction of serum-cholesterol by dextro-thyroxine in men with coronary heart disease. Lancet , 1: 783, 1961.
28.
Greiner, T. , et al.: A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort. Am. J. Med., 9: 143, 1960.
29.
Findley, T. : The placebo and the physician. Med. Clin. North America, 37: 1821, 1953.
30.
Wolf, S., AND Pinsky, R.H.: Effects of placebo administration and occurrence of toxic reactions . J. A. M. A., 155: 339, 1954.
31.
Wolf, S.: Effects of suggestion and conditioning on the action of chemical agents in human subj ects—the pharmacology of placebos. J. Clin. Invest. 29: 100, 1950.
32.
Russek, H.I. : Evaluation of the nitrites in the treatment of angina pectoris. Am. J. M. Sc., 239: 478, 1960 .
33.
Shoshkes, M. , et al.: Iproniazid in angina pectoris: a double blind study. Circulation, 20: 17, 1959.
34.
Owen, W.R.: Effect of sodium D-thyroxine on serum cholesterol in man. Medecine et Hygiene, No. 506: 462, 1961.
35.
Bender, S.R. : Sodium D-thyroxine in the therapy of hypercholesterolemia of coronary artery disease. Abstr. Tenth Annual Convention, TheAmerican College of Cardiology, New York, N. Y., May 17 to 20, 1961.
36.
Jones, R.J.: Hypercholesterolemia in patients with coronary disease influenced by D-thyroxine administration. Symposium on Sodium D-thyroxine and Hypercholesterolemia. Baxter Laboratories , Chicago, 1960.